268 related articles for article (PubMed ID: 23583403)
1. Sulforaphane inhibits the engagement of LPS with TLR4/MD2 complex by preferential binding to Cys133 in MD2.
Koo JE; Park ZY; Kim ND; Lee JY
Biochem Biophys Res Commun; 2013 May; 434(3):600-5. PubMed ID: 23583403
[TBL] [Abstract][Full Text] [Related]
2. Suppression of Toll-like receptor 4 activation by caffeic acid phenethyl ester is mediated by interference of LPS binding to MD2.
Kim SY; Koo JE; Seo YJ; Tyagi N; Jeong E; Choi J; Lim KM; Park ZY; Lee JY
Br J Pharmacol; 2013 Apr; 168(8):1933-45. PubMed ID: 23231684
[TBL] [Abstract][Full Text] [Related]
3. Sulforaphane suppresses oligomerization of TLR4 in a thiol-dependent manner.
Youn HS; Kim YS; Park ZY; Kim SY; Choi NY; Joung SM; Seo JA; Lim KM; Kwak MK; Hwang DH; Lee JY
J Immunol; 2010 Jan; 184(1):411-9. PubMed ID: 19949083
[TBL] [Abstract][Full Text] [Related]
4. Celastrol blocks binding of lipopolysaccharides to a Toll-like receptor4/myeloid differentiation factor2 complex in a thiol-dependent manner.
Lee JY; Lee BH; Kim ND; Lee JY
J Ethnopharmacol; 2015 Aug; 172():254-60. PubMed ID: 26116162
[TBL] [Abstract][Full Text] [Related]
5. Curcumin Analog L48H37 Prevents Lipopolysaccharide-Induced TLR4 Signaling Pathway Activation and Sepsis via Targeting MD2.
Wang Y; Shan X; Dai Y; Jiang L; Chen G; Zhang Y; Wang Z; Dong L; Wu J; Guo G; Liang G
J Pharmacol Exp Ther; 2015 Jun; 353(3):539-50. PubMed ID: 25862641
[TBL] [Abstract][Full Text] [Related]
6. Dynamic lipopolysaccharide transfer cascade to TLR4/MD2 complex via LBP and CD14.
Kim SJ; Kim HM
BMB Rep; 2017 Feb; 50(2):55-57. PubMed ID: 28115037
[TBL] [Abstract][Full Text] [Related]
7. Lipopolysaccharide (LPS) directly suppresses growth hormone receptor (GHR) expression through MyD88-dependent and -independent Toll-like receptor-4/MD2 complex signaling pathways.
Dejkhamron P; Thimmarayappa J; Kotlyarevska K; Sun J; Lu C; Bonkowski EL; Denson LA; Menon RK
Mol Cell Endocrinol; 2007 Aug; 274(1-2):35-42. PubMed ID: 17601656
[TBL] [Abstract][Full Text] [Related]
8. Arachidonic acid inhibits inflammatory responses by binding to myeloid differentiation factor-2 (MD2) and preventing MD2/toll-like receptor 4 signaling activation.
Zhang Y; Chen H; Zhang W; Cai Y; Shan P; Wu D; Zhang B; Liu H; Khan ZA; Liang G
Biochim Biophys Acta Mol Basis Dis; 2020 May; 1866(5):165683. PubMed ID: 31953218
[TBL] [Abstract][Full Text] [Related]
9. Sialyl residues modulate LPS-mediated signaling through the Toll-like receptor 4 complex.
Feng C; Stamatos NM; Dragan AI; Medvedev A; Whitford M; Zhang L; Song C; Rallabhandi P; Cole L; Nhu QM; Vogel SN; Geddes CD; Cross AS
PLoS One; 2012; 7(4):e32359. PubMed ID: 22496731
[TBL] [Abstract][Full Text] [Related]
10. Melatonin-sulforaphane hybrid ITH12674 attenuates glial response in vivo by blocking LPS binding to MD2 and receptor oligomerization.
Michalska P; Buendia I; Duarte P; FernandezMendivil C; Negredo P; Cuadrado A; López MG; Leon R
Pharmacol Res; 2020 Feb; 152():104597. PubMed ID: 31838078
[TBL] [Abstract][Full Text] [Related]
11. Recent progress in the discovery of myeloid differentiation 2 (MD2) modulators for inflammatory diseases.
Chen L; Fu W; Zheng L; Wang Y; Liang G
Drug Discov Today; 2018 Jun; 23(6):1187-1202. PubMed ID: 29330126
[TBL] [Abstract][Full Text] [Related]
12. CD40-mediated up-regulation of Toll-like receptor 4-MD2 complex on the surface of murine dendritic cells.
Frleta D; Noelle RJ; Wade WF
J Leukoc Biol; 2003 Dec; 74(6):1064-73. PubMed ID: 12960264
[TBL] [Abstract][Full Text] [Related]
13. Artemisinin inhibits TLR4 signaling by targeting co-receptor MD2 in microglial BV-2 cells and prevents lipopolysaccharide-induced blood-brain barrier leakage in mice.
Zhang T; Zhang X; Lin C; Wu S; Wang F; Wang H; Wang Y; Peng Y; Hutchinson MR; Li H; Wang X
J Neurochem; 2021 May; 157(3):611-623. PubMed ID: 33453127
[TBL] [Abstract][Full Text] [Related]
14. A Single Step
Jagtap P; Prasad P; Pateria A; Deshmukh SD; Gupta S
Front Immunol; 2020; 11():5. PubMed ID: 32038655
[TBL] [Abstract][Full Text] [Related]
15. The molecular basis of the host response to lipopolysaccharide.
Bryant CE; Spring DR; Gangloff M; Gay NJ
Nat Rev Microbiol; 2010 Jan; 8(1):8-14. PubMed ID: 19946286
[TBL] [Abstract][Full Text] [Related]
16. Key residues in TLR4-MD2 tetramer formation identified by free energy simulations.
Tafazzol A; Duan Y
PLoS Comput Biol; 2019 Oct; 15(10):e1007228. PubMed ID: 31609969
[TBL] [Abstract][Full Text] [Related]
17. Chalcone derivatives ameliorate lipopolysaccharide-induced acute lung injury and inflammation by targeting MD2.
Zhang YL; Zhang WX; Yan JQ; Tang YL; Jia WJ; Xu ZW; Xu MJ; Chattipakorn N; Wang Y; Feng JP; Liu ZG; Liang G
Acta Pharmacol Sin; 2022 Jan; 43(1):76-85. PubMed ID: 34480112
[TBL] [Abstract][Full Text] [Related]
18. Carbon monoxide down-modulates Toll-like receptor 4/MD2 expression on innate immune cells and reduces endotoxic shock susceptibility.
Riquelme SA; Bueno SM; Kalergis AM
Immunology; 2015 Feb; 144(2):321-32. PubMed ID: 25179131
[TBL] [Abstract][Full Text] [Related]
19. An MD2-derived peptide promotes LPS aggregation, facilitates its internalization in THP-1 cells, and inhibits LPS-induced pro-inflammatory responses.
Tandon A; Harioudh MK; Ishrat N; Tripathi AK; Srivastava S; Ghosh JK
Cell Mol Life Sci; 2018 Jul; 75(13):2431-2446. PubMed ID: 29313060
[TBL] [Abstract][Full Text] [Related]
20. MD2 mediates angiotensin II-induced cardiac inflammation and remodeling via directly binding to Ang II and activating TLR4/NF-κB signaling pathway.
Han J; Zou C; Mei L; Zhang Y; Qian Y; You S; Pan Y; Xu Z; Bai B; Huang W; Liang G
Basic Res Cardiol; 2017 Jan; 112(1):9. PubMed ID: 28013347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
